These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10596931)

  • 1. The association of Clostridium botulinum type C with equine grass sickness: a toxicoinfection?
    Hunter LC; Miller JK; Poxton IR
    Equine Vet J; 1999 Nov; 31(6):492-9. PubMed ID: 10596931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of mucosal IgA in the equine small intestine: specific IgA in cases of acute grass sickness and controls.
    Nunn FG; Pirie RS; McGorum B; Wernery U; Poxton IR
    Equine Vet J; 2007 Sep; 39(5):457-60. PubMed ID: 17910272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)?
    Hunter LC; Poxton IR
    Equine Vet J; 2001 Nov; 33(6):547-53. PubMed ID: 11720025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Clostridium perfringens in faeces and ileal contents from grass sickness affected horses: comparisons with 3 control populations.
    Waggett BE; McGorum BC; Wernery U; Shaw DJ; Pirie RS
    Equine Vet J; 2010 Sep; 42(6):494-9. PubMed ID: 20716188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of equine grass sickness with evidence for soil-borne origin involving botulinum neurotoxin.
    Böhnel H; Wernery U; Gessler F
    J Vet Med B Infect Dis Vet Public Health; 2003 May; 50(4):178-82. PubMed ID: 12916691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of antibotulinum neurotoxin type C antibodies in horses in Israel.
    Steinman A; Kachtan I; Levi O; Shpigel NY
    Equine Vet J; 2007 May; 39(3):232-5. PubMed ID: 17520974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study.
    McCarthy HE; French NP; Edwards GB; Poxton IR; Kelly DF; Payne-Johnson CE; Miller K; Proudman CJ
    Equine Vet J; 2004 Mar; 36(2):123-9. PubMed ID: 15038434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya.
    McGorum BC; Scholes S; Milne EM; Eaton SL; Wishart TM; Poxton IR; Moss S; Wernery U; Davey T; Harris JB; Pirie RS
    Equine Vet J; 2016 Nov; 48(6):786-791. PubMed ID: 26640078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epidemiological study of risk factors associated with the recurrence of equine grass sickness (dysautonomia) on previously affected premises.
    Newton JR; Hedderson EJ; Adams VJ; McGorum BC; Proudman CJ; Wood JL
    Equine Vet J; 2004 Mar; 36(2):105-12. PubMed ID: 15038431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outbreaks of equine grass sickness in Hungary.
    Schwarz B; Brunthaler R; Hahn C; van den Hoven R
    Vet Rec; 2012 Jan; 170(3):75. PubMed ID: 22124026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the intestinal microbiota of healthy horses and those suffering from equine grass sickness.
    Garrett LA; Brown R; Poxton IR
    Vet Microbiol; 2002 Jun; 87(1):81-8. PubMed ID: 12079749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Key-Gaskell syndrome and infection by Clostridium botulinum type C/D.
    Nunn F; Cave TA; Knottenbelt C; Poxton IR
    Vet Rec; 2004 Jul; 155(4):111-5. PubMed ID: 15328740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine dysautonomia: has grass been blamed unfairly all this time?
    Wood JL; McGorum BC; Mayhew IG
    Equine Vet J; 1999 Nov; 31(6):451-2. PubMed ID: 10596923
    [No Abstract]   [Full Text] [Related]  

  • 14. Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions.
    McGorum BC; Davey T; Dosi MCM; Keen JA; Morrison LR; Pirie RS; Shaw DJ; Harris JB
    Equine Vet J; 2024 Feb; ():. PubMed ID: 38301732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurology and enterology of equine grass sickness: a review of basic mechanisms.
    Cottrell DF; McGorum BC; Pearson GT
    Neurogastroenterol Motil; 1999 Apr; 11(2):79-92. PubMed ID: 10320588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of the Fecal Microbiota and Biomarker Discovery in Equine Grass Sickness.
    Leng J; Proudman C; Darby A; Blow F; Townsend N; Miller A; Swann J
    J Proteome Res; 2018 Mar; 17(3):1120-1128. PubMed ID: 29364680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing a field trial of an equine grass sickness vaccine: A questionnaire-based feasibility study.
    Ireland JL; McGorum BC; Proudman CJ; Newton JR
    Vet J; 2016 Jul; 213():64-71. PubMed ID: 27240918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clustering of equine grass sickness cases in the United Kingdom: a study considering the effect of position-dependent reporting on the space-time K-function.
    French NP; McCarthy HE; Diggle PJ; Proudman CJ
    Epidemiol Infect; 2005 Apr; 133(2):343-8. PubMed ID: 15816161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equine grass sickness: epidemiology, diagnosis, and global distribution.
    Wylie CE; Proudman CJ
    Vet Clin North Am Equine Pract; 2009 Aug; 25(2):381-99. PubMed ID: 19580947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness.
    McGorum BC; Pirie RS; Shaw D; Macintyre N; Cox A
    Equine Vet J; 2016 Nov; 48(6):773-778. PubMed ID: 26518231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.